Literature Update for CERGA May - July 2009
Contents
Page #List of journal checked / …….. / 2
List of agencies checked / …….. / 2
List of references …
Alcohol / …….. / 3
Opiate treatment / …….. / 4
Treatment organisation and delivery / …….. / 4
Epidemiology and demography / …….. / 5
Co-morbidity / …….. / 5
Psychosocial treatments / …….. / 6
Psychostimulants / …….. / 6
Blood borne viruses / …….. / 6
Overdose prevention and harm reduction / …….. / 7
Pregnancy treatment / …….. / 7
List of abstracts … / Alcohol / …….. / 8
Opiate treatment / …….. / 13
Treatment organisation and delivery / …….. / 16
Epidemiology and demography / …….. / 19
Co-morbidity / …….. / 22
Psychosocial treatments / …….. / 23
Psychostimulants / …….. / 26
Blood borne viruses / …….. / 27
Overdose prevention and harm reduction / …….. / 29
Pregnancy treatment / …….. / 30
List of Journals / Issues / year / Volumes & issues checked and
comments
Addiction / 12 / 104 (5) May; 104 (6) June; 104 (7) July
Addiction Research and Theory / 6 / 17 (3) Jun; 17 (4) Aug
Addictive Behaviours / 34 (5) May; 34 (6 & 7) Jun-July
Addictive Disorders and their Treatment / 4 / 8 (2) Jun; 8 (3) Sept
Alcoholism / Not on UoA e-Journals catalogue: on NHS e-lib but only 2005-2008
Alcoholism and Drug Abuse Weekly / Not on UoA e-Journals catalogue: on NHS e-lib
Alcoholism: Clinical and Experimental Research / 12 / 33 (5) May; 33 (6) June; 33 (7) July
American Journal of Drug and Alcohol Abuse / 6 / 35 (3) May; 35 (4) July
American Journal on Addictions / 6 / 18 (3) May; 18 (4) July
British Medical Journal International / Weekly / 338 (7702) – 338 (7714) 2 May-25 July
Drug and Alcohol Dependency / Not on UoA e-Journals catalogue nor on NHS e-lib
Drug and Alcohol Review / 6 / Changed publisher in 2009; no ’09 issues found on UoA e-Journals catalogue, most recent - 2008
Drugs and Alcohol Today / 4 / Not on UoA e-Journals catalogue: on NHS e-lib
Drugs: Education, Prevention and Policy / 6 / 16 (3) June; 16 (4) Aug
Forensic Science International / 187 (1-3) May; 188 (1-3) July; 189 (1-3) Aug
International Journal of Drug Policy / 6 / Not on UoA e-Journals catalogue; on NHS e-lib
20 (3) May; 20 (4) July
Journal of Addictive Diseases / 4 / 28 (2); 28 (3)
Journal of Alcohol and Drug Education / Not on UoA e-Journals catalogue: on NHS e-lib
Journal of Public Health / 6 / 17 (3) June; 17 (4) Aug
Journal of Substance Abuse Treatment / 36 (3) April; 36 (4) June; 37 (1) July
Journal of Substance Use and Misuse / 6 / 14 (3&4) June
Lancet / Weekly / 373 (9674) Apr/May – 373 (9686) July
List of Agencies:
National Treatment Agency PublicationsList of References
Note: number in [ ] after reference is page number for abstract
Alcohol
1. Alcohol-related cirrhosis—early abstinence is a key factor in prognosis, even in the most severe cases. Addiction 2009 104 (5): 768-774. Clare Verrill, Hannah Markham, Alexa Templeton, Norman J. Carr, Nick Sheron [p 8]
2. Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction 2009 104 (6): 927-939. Felicia W. Chi, Lee A. Kaskutas, Stacy Sterling, Cynthia I. Campbell, Constance Weisner [p 8]
3. How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addiction Research & Theory 17 (3):236 – 259. John Francis Kelly a; Molly Magill b; Robert Lauren Stout c [p 8]
4. Cognitive-behavioral therapy for panic disorder in patients being treated for alcohol dependence: Moderating effects of alcohol outcome expectancies. Addictive Behaviours Volume 34 (6-7): 554-560. Matt G. Kushner, Sandra Sletten, Christopher Donahue, Paul Thuras, Eric Maurer, Antonina Schneider, Brenda Frye, Joani Van Demark [p 9]
5. Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence. Addictive Behaviours 34(6-7): 581-586. Kyle M. Kampman, Helen M. Pettinati, Kevin G. Lynch, Hu Xie, Charles Dackis, David W. Oslin, Thorne Sparkman, Tiffany Sharkoski, Charles P. O'Brien [p 10]
6. Understanding and Treating Patients With Alcoholic Cirrhosis: An Update. Alcoholism: Clinical and Experimental Research 33 (7): 1136-1144. Giovanni Addolorato, Marcia Russell, Emanuele Albano, Paul S. Haber, Jack R. Wands, Lorenzo Leggio [p 10]
7. GPs should get specific training on dealing with patients’ alcohol problems, MPs hear. British Medical Journal 338 (7704): b1913. Adrian O’Dowd, London. [News] [p11]
8. The Cost Effectiveness of Naltrexone Added to Cognitive-Behavioral Therapy in the Treatment of Alcohol Dependence. Journal of Addictive Diseases 28 (2): 137 – 144. David Walters; Jason P. Connor; Gerald F. X. Feeney; Ross McD Young [p12]
9. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 373 (9682): 2234-2246. Peter Anderson, Dan Chisholm, Daniela C Fuhr [p 12]
10. Engagement and Retention in Outpatient Alcoholism Treatment for Women. American Journal on Addictions 18 (4): 277 – 288. Fiona S. Graff; Thomas J. Morgan; Elizabeth E. Epstein; Barbara S. McCrady; Sharon M. Cook; Noelle K. Jensen; Shalonda Kelly [p 12]
Opiate Treatment
11. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction 2009 104 (5): 775-783. Caleb J. Banta-Green, Charles Maynard, Thomas D. Koepsell, Elizabeth A. Wells, Dennis M. Donovan [p 13]
12. Comparison of costs and utilization among buprenorphine and methadone patients. Addiction 2009 104 (6): 982-992. Paul G. Barnett [p13]
13. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction 2009 104 (7): 1193-1200. James Bell, Lieu Trinh, Bethany Butler, Deborah Randall, George Rubin [p 13]
14. Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program. Journal of Substance Abuse Treatment 36 (3): 306-312. Jennifer R. Havens, Carl A. Latkin, Minya Pu, Llewellyn J. Cornelius, David Bishai, Steve Huettner, Charles Rapp, Erin P. Ricketts, Jacqueline J. Lloyd, Steffanie A. Strathdee [p14]
15. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence. Journal of Substance Abuse Treatment 37 (1): 95-100. Gayle Ridge, Michael Gossop, Nicholas Lintzeris, John Witton, John Strang [p14]
16. Baseline Neurocognitive Profiles Differentiate Abstainers and Non-Abstainers in a Cocaine Clinical Trial. Journal of Addictive Diseases 28 (3): 250 – 257. Joy M. Schmitz; Marc E. Mooney; Charles E. Green; Scott D. Lane; Joel L. Steinberg; Alan C. Swann; F. Gerard Moeller [p15]
17. Inadequate Dose of Opioid-agonist Medication is Related to Misuse of Benzodiazepines. Addictive Disorders & Their Treatment 8 (3): 145-153. Heikman, Pertti Kalevi; Ojanpera, Ilkka Antero [p15]
18. Prescribing Injectable Methadone: What the Addiction Specialist Needs to Know. Addictive Disorders & Their Treatment 8 (3): 154-158. George, Sanju MRCPsych *; Dharmadhikari, Anupam [15]
Treatment Organisation and Delivery
19. Improving substance abuse treatment enrollment in community syringe exchangers. Addiction 2009 104 (5): p 786-795. Michael Kidorf, Van L. King, Karin Neufeld, Jessica Peirce, Ken Kolodner, Robert K. Brooner [p16]
20. Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users. Addiction 2009 104 (6): p 959-971. Christy K Scott, Michael L. Dennis [p 16]
21. Health professionals' attitudes towards AOD-related work: Moving the traditional focus from education and training to organizational culture. Drugs: education, prevention and policy 16 (3): 232 – 249. Natalie Skinner a; Ann M. Roche a; Toby Freeman a; Anna Mckinnon a [p16]
22. User involvement in efforts to improve the quality of drug misuse services in England: A national survey. Drugs: education, prevention and policy 16 (4): 364 – 377. Sue Patterson; Tim Weaver; Kostas Agath; Deborah Rutter; Eliot Albert; Mike J. Crawford [p 17]
23. Does a History of Violence Influence Treatment, Self-Help, and 1-Year Outcomes in Substance Use Disorder Patients? Journal of Addictive Diseases 28 (2): 171 – 179. Renee Schneider; Christine Timko [p 17]
24. Relating counselor attributes to client engagement in England. Journal of Substance Abuse Treatment 36 (3): 313-320. Dwayne Simpson, Grace A. Rowan-Szal, George W. Joe, David Best, Ed Day, Angela Campbell [p 17]
25. Organizational determinants of outpatient substance abuse treatment duration in women. Journal of Substance Abuse Treatment 37 (1): 64-72. Cynthia I. Campbell, Jeffrey A. Alexander, Christy Harris Lemak [p 18]
26. The evaluation of a trial of syringe vending machines in Canberra, Australia. International Journal of Drug Policy 20 (4): 336-339. David McDonald [p 18]
27. Secondary exchange of sterile injecting equipment in a high distribution environment: A mixed method analysis in south east Sydney, Australia. International Journal of Drug Policy 20 (4): 324-328. Joanne Bryant, Max Hopwood [p 18]
Epidemiology and Demography
28. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003–06). Addiction 2009 104 (7): 1233-1240. Jean-Noël Marzo, Michel Rotily, Fadi Meroueh, Marina Varastet, Catherine Hunault, Ivana Obradovic, Adeline Zin [p 19]
29. Groin injecting in injectable opioid treatment service users in South London. Addiction Research & Theory 17 (4): 381 - . Peter G. Miller a; Luciana Forzisi b; Deborah Zador c; Nick Lintzeris d; Nicola Metrebian b; Rob Van Der Waal e; Soraya Mayet b; John Strang b [p20]
30. Prospective Study of the Association Between Neurobehavior Disinhibition and Peer Environment on Illegal Drug Use in Boys and Girls. American Journal of Drug and Alcohol Abuse 35 (3): 145 – 150. Levent Kirisci; Ada C. Mezzich; Maureen Reynolds; Ralph E. Tarter; Sema Aytaclar [p 20]
31. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ2009;338:b2225. C McCowan, B Kidd, T Fahey [p 21]
32. Sex work, substance misuse and service provision: The experiences of female sex workers in south London. Drugs: education, prevention and policy, 16 (4): 355 – 363. Brenda Mosedale; Christos Kouimtsidis; Martina Reynolds [p 21]
33. Epidemiological Trends in Abuse and Misuse of Prescription Opioids. Journal of Addictive Diseases 28 (2):130 – 136. Henry Spiller; Douglas J. Lorenz; Elise J. Bailey; Richard C. Dart [p21]
34. Pathways from Adolescent Parent-Child Conflict to Substance Use Disorders in the Fourth Decade of Life. American Journal on Addictions 18 (3): 235 – 242. Judith S. Brook; David W. Brook; Chenshu Zhang; Patricia Cohen [p 22]
35. A profile of adolescent cocaine use in Northern Ireland. International Journal of Drug Policy 20 (4): 357-364. Patrick McCrystal, Andrew Percy [p 22]
Co-morbidity
36. Co-morbidity of drug addiction: An analysis of epidemiological data and possible etiological models. Addiction Research & Theory 17(4): 420 – 431. Author: Zsolt Demetrovics a [p 22]
37. Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addictive Behaviours 34 (6-7): 498-504. Christine E. Grella, Mitchell P. Karno, Umme S. Warda, Noosha Niv, Alison A. Moore [p 23]
Psychosocial Treatment
38. Social anxiety impacts willingness to participate in addiction treatment. Addictive Behaviours 34 (5): 474-476. Sarah W. Book, Suzanne E. Thomas, Jared P. Dempsey, Patrick K. Randall, Carrie L. Randall [p 23]
39. Parenting Practices as Mediators of Treatment Effects in an Early-Intervention Trial of Multidimensional Family Therapy. American Journal of Drug and Alcohol Abuse 35 (4): 220-226. Craig E. Henderson; Cindy L. Rowe; Gayle A. Dakof; Sam W. Hawes; Howard A. Liddle [p 24]
40. Assessing the effectiveness of an Internet-based videoconferencing platform for delivering intensified substance abuse counseling. Journal of Substance Abuse Treatment 36 (3): 331-338. Van L. King, Kenneth B. Stoller, Michael Kidorf, Kori Kindbom, Steven Hursh, Thomas Brady, Robert K. Brooner [p 24]
41. Informal discussions in substance abuse treatment sessions. Journal of Substance Abuse Treatment 36 (4): 366-375. Steve Martino, Samuel A. Ball, Charla Nich, Tami L. Frankforter, Kathleen M. Carroll [p 25]
42. Randomized trial of training and supervision in motivational interviewing with adolescent drug treatment practitioners. Journal of Substance Abuse Treatment 37 (1): 73-78. Luke Mitcheson, Kaanan Bhavsar, Jim McCambridge [p 25]
43. Acupuncture or counselling: outcomes and predictors of treatment choice in a non-statutory addiction service. Journal of Substance Use 14 (3&4): 151-160. Heather Ashton; Arunima Nodiyal; David Green; Brian Moore; Nick Heather [p 25]
Psychostimulatants
44. An audit of a stimulant clinic: changes in drug use, drug beliefs, and motivational ratings. Journal of Substance Use 14 (3 & 4): 179 – 188. L. Ramsay; Alyson Bond; Selina Pope [p 26]
45. Pharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine. American Journal of Drug and Alcohol Abuse 35 (3): 161 – 177.
Colin N. Haile; Thomas R. Kosten; Therese A. Kosten [p 26]
46. General practitioners’ management of psychostimulant drug misuse: Implications for education and training. Drugs: education, prevention and policy, 16 (4): 343 – 354. Ahmed Alkhamis; Catriona Matheson; Christine Bond [p 26]
47. Theories of Addiction: Methamphetamine Users' Explanations for Continuing Drug Use and Relapse. American Journal on Addictions 18 (4): 294 – 300. Thomas F. Newton; Richard De La Garza II; Ari D. Kalechstein; Desey Tziortzis; Caitlin A. Jacobsen [p 27]
Blood Borne Viruses
48. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ2009;338:b1649. Evan Wood, Thomas Kerr, Brandon D L Marshall, Kathy Li, Ruth Zhang, Robert S Hogg, P Richard Harrigan, Julio S G Montaner [p 27]
49. Managing hepatitis C virus infection. BMJ 2009;338 (7711):b2366. Kathryn L Nash, Ian Bentley, Gideon M Hirschfield. Clinical Review [p 28]
50. Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. Journal of Substance Abuse Treatment 37 (1): 32-40. Alain H. Litwin, Kenneth A. Harris Jr., Shadi Nahvi, Philippe J. Zamor, Irene J. Soloway, Peter L. Tenore, Daniel Kaswan, Marc. N. Gourevitch, Julia H. Arnsten [p 28]
Overdose Prevention and Harm Reduction
51. Using a group approach to preventing heroin overdose in North London. Drugs: education, prevention and policy 16 (4): 328 – 342. Peter Phillips; Chris Glover; Teresa Allan; Mary Ellen Khoo [p 29]
52. Preventing Death Among the Recently Incarcerated: An Argument for Naloxone Prescription Before Release. Journal of Addictive Diseases 28 (2): 124 – 129. Sarah E. Wakeman; Sarah E. Bowman; Michelle McKenzie; Alexandra Jeronimo; Josiah D. Rich [p 29]